Clinical trial
F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer
NCT01985971 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- August 19, 2016
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain metastases from breast cancer